Therapeutic effects of organic zinc on reproductive hormones, insulin resistance and mTOR expression, as a novel component, in a rat model of Polycystic ovary syndrome

被引:16
作者
Torshizi, Faeze Fazel [1 ]
Chamani, Mohammad [1 ]
Khodaei, Hamid Reza [2 ]
Sadeghi, Ali Asghar [1 ]
Hejazi, Seyed Hossein [3 ]
Heravi, Reza Majidzadeh [4 ]
机构
[1] Islamic Azad Univ, Sci & Res Branch, Dept Anim Sci, Tehran, Iran
[2] Islamic Azad Univ, Golpayegan Branch, Dept Anim Sci, Esfahan, Iran
[3] Isfahan Univ Med Sci, Sch Med, Skin Dis & Leishmaniasis Res Ctr, Dept Parasitol & Mycol, Esfahan, Iran
[4] Ferdowsi Univ Mashhad, Dept Anim Sci, Mashhad, Razavi Khorasan, Iran
关键词
Insulin resistance; mTOR; Polycystic ovary syndrome; Rat; Zinc-methionine; MAMMALIAN TARGET; ESTRADIOL VALERATE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; RAPAMYCIN; GROWTH; SUPPLEMENTATION; IMPROVEMENT; METABOLISM;
D O I
10.22038/IJBMS.2019.36004.8586
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): Zinc is an effective factor in the reproductive system. Insulin resistance (IR) is known as an important disorder in patients with polycystic ovary syndrome (PCOS). Mammalian target of rapamycin (mTOR), which controls key cell activities, in particular, is activated in disorders such as PCOS. The present study was conducted to observe the therapeutic effects of organic zinc on IR, mTOR gene expression, and pathogenesis of PCOS in a rat model induced-PCOS. Materials and Methods: Experimental treatments were performed on control and treated groups, consisting of healthy controls (Control, water, and standard feed intake and daily injection of sesame oil alone), Polycystic control (PCO, injection of 4 mg/kg estradiol valerate (EV) for four weeks). Treated groups (PCO-ZM 25, PCO-ZM 75, and PCO-ZM 175) after 4 weeks of receiving EV, were daily given three levels of 25, 75, and 175 mg zinc methionine/kg BW for 15 days, respectively. Results: Injection of EV dramatically increased body and ovarian weights, levels of LH, testosterone, estradiol, triglyceride, fasting insulin, fasting glucose, HOMA-IR, IGF-1, gene expression of mTOR, and number of cysts (P<0.05). It also reduced the level of progesterone, HDL-C, and the number of antral follicles (P<0.05). However, by increasing zinc-methionine application especially at 175 mg/kg BW, the induction effects of EV were improved on ovarian cysts (P<0.05). Conclusion: Organic zinc showed beneficial effects in the EV induced PCOS rats via decreased insulin resistance and mTOR expression, restored the hormonal profile, and decreased the number of cysts in the ovaries.
引用
收藏
页码:36 / 45
页数:10
相关论文
共 50 条
[21]   Therapeutic potentials of the caffeine in polycystic ovary syndrome in a rat model: Via modulation of proinflammatory cytokines and antioxidant activity [J].
Raoofi, Amir ;
Rezaie, Mohammad Jafar ;
Delbari, Ali ;
Ghoreishi, Seyed Amir-Hossein ;
Sichani, Pegah Hadi ;
Maleki, Shahram ;
Nasiry, Davood ;
Akhlaghi, Maedeh ;
Ebrahimi, Vahid ;
Khaneghah, Amin Mousavi .
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2022, 50 (06) :137-146
[22]   Nicotinamide Mononucleotide Improves Endometrial Homeostasis in a Rat Model of Polycystic Ovary Syndrome by Decreasing Insulin Resistance and Regulating the Glylytic Pathway [J].
Zhang, Wenhui ;
Zhang, Jiaming ;
Xue, Haoxuan ;
Chen, Xi ;
Li, Meixiang ;
Chen, Shenghua ;
Li, Zhiling ;
Sechi, Leonardo Antonio ;
Wang, Qian ;
Capobianco, Giampiero ;
Lei, Xiaocan .
MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (21)
[23]   Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy [J].
Teede, Helena J. ;
Meyer, Caroline ;
Hutchison, Samantha K. ;
Zoungas, Sophia ;
McGrath, Barry P. ;
Moran, Lisa J. .
FERTILITY AND STERILITY, 2010, 93 (01) :184-191
[24]   Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome [J].
Belli, SH ;
Graffigna, MN ;
Oneto, A ;
Otero, P ;
Schurman, L ;
Levalle, OA .
FERTILITY AND STERILITY, 2004, 81 (03) :624-629
[25]   The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome [J].
Mellati, Ali Awsat ;
Sharifi, Faranak ;
Sajadinejad, Mohsen ;
Sohrabi, Davood ;
Mazloomzadeh, Saeideh .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (01) :39-44
[26]   Effect of impaired sensitivity to thyroid hormones on the risk of insulin resistance and dyslipidemia in polycystic ovary syndrome patients [J].
You, Yang ;
Li, Xiaohui ;
Guo, Zaixin ;
Hong, Xinyu ;
Yu, Qi .
GYNECOLOGICAL ENDOCRINOLOGY, 2025, 41 (01)
[27]   Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome [J].
Alan, Murat ;
Gurlek, Beril ;
Yilmaz, Alpay ;
Aksit, Murat ;
Aslanipour, Behnaz ;
Gulhan, Ibrahim ;
Mehmet, Calan ;
Taner, Cuneyt Eftal .
GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (03) :220-223
[28]   Metformin activates SIRT2 to improve insulin resistance and promote granulosa cell glycolysis in a rat model of polycystic ovary syndrome [J].
Zhang, Zhihan ;
Huo, Peng ;
Lei, Xiaocan ;
Xue, Haoxuan ;
Yang, Xiuli ;
Le, Jianghua ;
Zhang, Shun .
REPRODUCTIVE BIOMEDICINE ONLINE, 2025, 50 (05)
[29]   A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice [J].
Kauffman, Alexander S. ;
Thackray, Varykina G. ;
Ryan, Genevieve E. ;
Tolson, Kristen P. ;
Glidewell-Kenney, Christine A. ;
Semaan, Sheila J. ;
Poling, Matthew C. ;
Iwata, Nahoko ;
Breen, Kellie M. ;
Duleba, Antoni J. ;
Stener-Victorin, Elisabet ;
Shimasaki, Shunichi ;
Webster, Nicholas J. ;
Mellon, Pamela L. .
BIOLOGY OF REPRODUCTION, 2015, 93 (03)
[30]   Screening for Insulin Resistance in Polycystic Ovary Syndrome Views of Physician Members of the American Society for Reproductive Medicine [J].
Asante, Albert ;
Omurtag, Kenan ;
Stewart, Elizabeth A. ;
Coddington, Charles C. .
JOURNAL OF REPRODUCTIVE MEDICINE, 2015, 60 (9-10) :371-377